[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2024073678A3 - Phospholipids containing a heterocycle ring having a tertiary amine or amide - Google Patents

Phospholipids containing a heterocycle ring having a tertiary amine or amide Download PDF

Info

Publication number
WO2024073678A3
WO2024073678A3 PCT/US2023/075535 US2023075535W WO2024073678A3 WO 2024073678 A3 WO2024073678 A3 WO 2024073678A3 US 2023075535 W US2023075535 W US 2023075535W WO 2024073678 A3 WO2024073678 A3 WO 2024073678A3
Authority
WO
WIPO (PCT)
Prior art keywords
amide
tertiary amine
heterocycle ring
phospholipids containing
subject
Prior art date
Application number
PCT/US2023/075535
Other languages
French (fr)
Other versions
WO2024073678A2 (en
Inventor
Qi-Ying Hu
Shengyan Liu
Linli Wei
Original Assignee
Omega Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omega Therapeutics, Inc. filed Critical Omega Therapeutics, Inc.
Publication of WO2024073678A2 publication Critical patent/WO2024073678A2/en
Publication of WO2024073678A3 publication Critical patent/WO2024073678A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/11—Esters of phosphoric acids with hydroxyalkyl compounds without further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532—Seven-(or more) membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The current disclosure relates to lipid-based compositions and methods of administering therapeutic agents relating thereto. In particular, the disclosure relates to novel phospholipids containing a heterocycle ring having a tertiary amine or amide that may be incorporated into lipidbased compositions to increase efficiency of delivery of a therapeutic agent(s) to tissues of a subject, including lung tissues of a subject.
PCT/US2023/075535 2022-09-30 2023-09-29 Phospholipids containing a heterocycle ring having a tertiary amine or amide WO2024073678A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202263378043P 2022-09-30 2022-09-30
US63/378,043 2022-09-30
US202263380218P 2022-10-19 2022-10-19
US63/380,218 2022-10-19
US202263380470P 2022-10-21 2022-10-21
US63/380,470 2022-10-21

Publications (2)

Publication Number Publication Date
WO2024073678A2 WO2024073678A2 (en) 2024-04-04
WO2024073678A3 true WO2024073678A3 (en) 2024-06-06

Family

ID=90479319

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2023/075535 WO2024073678A2 (en) 2022-09-30 2023-09-29 Phospholipids containing a heterocycle ring having a tertiary amine or amide

Country Status (1)

Country Link
WO (1) WO2024073678A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5094848A (en) * 1989-06-30 1992-03-10 Neorx Corporation Cleavable diphosphate and amidated diphosphate linkers
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
WO2008119146A2 (en) * 2007-03-29 2008-10-09 Dair, Bicudo Piai Combi-preparation of phosphoethanolamine and omega-3-fatty acid for treating bronchial asthma and copd

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5094848A (en) * 1989-06-30 1992-03-10 Neorx Corporation Cleavable diphosphate and amidated diphosphate linkers
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
WO2008119146A2 (en) * 2007-03-29 2008-10-09 Dair, Bicudo Piai Combi-preparation of phosphoethanolamine and omega-3-fatty acid for treating bronchial asthma and copd

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EBERT ET AL.: "Passive Permeability of Planar Lipid Bilayers to Organic Anions", BIOPHYSICAL JOURNAL, vol. 115, 2018, pages 1931 - 1941, XP085541047, DOI: 10.1016/j.bpj.2018.09.025 *

Also Published As

Publication number Publication date
WO2024073678A2 (en) 2024-04-04

Similar Documents

Publication Publication Date Title
MX2021008358A (en) Lipids for lipid nanoparticle delivery of active agents.
EP2368900A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
TW200510391A (en) Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
MXPA02005536A (en) New aminopropylphosphinic acids.
TW200736223A (en) N-(pyridin-2-yl)-sulfonamide derivatives
IT1252868B (en) ANTI-PHALALGIC PHARMACEUTICAL COMPOSITION FOR ENDONASAL ADMINISTRATION, PROCEDURE TO PREPARE IT AND ITS THERAPEUTIC USE
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
WO2005037860A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
BG106013A (en) New compounds and compositions as protease inhibitors
BR112013026706A2 (en) nutritional compositions comprising alpha hydroxy isocaproic acid
MY132924A (en) Hematopoietic stimulation
WO2005077969A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
MY148123A (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
TW200614992A (en) Combinations for the treatment of diseases involving cell proliferation
AU7315301A (en) Compounds and compositions for delivering active agents
RS20090083A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta -mimetics
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
IL149336A0 (en) Phenyl amine carboxylic acid compounds and compositions for delivering active agents
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
MY149911A (en) Methods for administering long-lasting hypoglycemic agents
MY139203A (en) Pharmaceutical composition
WO2003072066A3 (en) Compositions and methods for the treatment of glaucoma and ocular hypertension
HUP0400548A2 (en) Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma
EP2279732A3 (en) Compounds and compositions for delivering active agents
UA90668C2 (en) Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves and an anti-inflammatory agent